Markets for Advanced Wound Care Technologies
Report Highlights
- The U.S. market for advanced wound care will increase from $3.0 billion in 2007 to an estimated $3.5 billion by the end of 2008. It should reach $6.0 billion in 2013, a compound annual growth rate (CAGR) of 11.7%.
- Wound care dressings, sealants and anti-adhesion products have the largest share of the market, worth $1.7 billion in 2007. This is expected to increase to more than $1.8 billion in 2008 and more than $3.0 billion in 2013, for a CAGR of 10.0%.
- Wound healing devices have the second largest market share, generating $1.3 billion in 2007 and an estimated $1.6 billion in 2008. This should increase at a CAGR of 13.4% to reach $3.0 billion in 2013.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This updated BCC Research report provides an overview of advanced wound care products, detailed market analyses and discussions of competitive environments. The study includes information about significant products, players, issues and trends and other information affecting the wound care industry.
REASONS FOR DOING THE STUDY
Advanced wound care technologies have emerged from the shadows to become, in the last 20 years, significant products in the treatment of wound care. While conventionally made wound care product proteins are considerable and generally less expensive, new products and biotechnological advancements are beginning to revolutionize future growth of the wound care market. New technological products are competing in a fast track market that seeks to improve the quality of life for millions of individuals needing both acute and chronic wound care.
Ongoing patient management studies will increase the number of indications, and keeping in touch with these applications for the various advanced wound care products is good business practice. This study will provide its readers with the knowledge to adequately view and assess the advanced wound care movement and will provide insight into market potential.
SCOPE OF REPORT
This document is designed to be a helpful business tool that will provide a thorough evaluation of the advanced wound care market. The scope of this study is U.S. based and identifies markets in five general segments:
- biological dressings
- surgical sealants
- synthetic dressings
- anti–adhesion products and other related wound healing products
- wound healing devices
Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses.
The advanced wound care industry consists of products that involve new techniques and therapies, are of benefit in healing wounds and result in lower costs for care. They incorporate biotechnological advancements and improved methods for dealing with wounds. Products in this study are considered to be at the forefront of wound care technology.
Traditional wound care products, those that have previously been used in the marketplace, are not addressed in this analysis. Industry experts classify “advanced wound care products” as those that include biological dressings, surgical sealants, synthetic dressings, anti–adhesion products and other related wound–healing products.
METHODOLOGY
Information for this report was obtained through primary and secondary data collection methods. Primary methods included interviews with more than 50 key executives, product managers, clinical specialists and other related key personnel involved in the wound care industry. Secondary methods included published literature, investment reports, company literature, and various business journals that have emphases on wound care and related areas.
Data for this report relates to the U.S. market in U.S. dollars at the manufacturers’ level. The base year of the report is 2007, with historical data provided for 2006 and forecast data provided for 2008 and 2013. Historical, base year and forecast data are provided for each market segment of the report.
Growth rates are determined through a compilation of data including past trends, future trends, demographics, incidence, mortality, products in research and development, current product growth, etc. Competitor market share estimates are provided for each market segment for the 2007 base year.
Frequently Asked Questions (FAQs)
Report Highlights
-
The total U.S. market for advanced wound care technologies was worth more than $2.3 billion in 2005. By the end of 2006 the market will reach almost $2.6 billion, and over a five-year period will grow at an average annual growth rate (AAGR) of 12.3% to reach $4.6 billion in 2011.
-
Wound care dressings, sealants, and antiadhesion products held the largest market share through the forecast period by a small margin, with 59.2% of the total market in 2006. By the end of 2011 the segment will hold 55% of the total U.S. market.
-
Wound healing devices account for a smaller portion of revenues with nearly 1.1 billion in estimated sales for 2006 or 40.8% of revenues. Products in this segment include electrostimulation products, hyperbaric oxygen therapies, vacuum assisted therapies, and other products.
Report Highlights
-
The total U.S. market for advanced wound care was estimated at more than $1.7 billion in 2003 and is expected to rise at an AAGR (average annual growth rate) of 10.2% to $2.8 billion.
-
Biological dressings, surgical sealants, synthetic dressings and other wound healing products account for $1.1 billion and will rise at an AAGR of 7.2%.
-
Wound healing devices, e.g., electrostimulation products, hyperbaric oxygen therapies and vacuum-assisted therapies, account for a smaller portion with $608.2 million in sales but are rising faster at an AAGR of 15%.
Report Highlights
- The total U.S. market for wound care products in 2000 exceeded $2.1 billion. Growing at an average annual rate (AAGR) of 10.1%, this market is forecast to exceed $3.4 billion in 2005.
- The market share for wound closing technologies will rise from 58.7% to over 63% in 2005, as this segment rises at an AAGR of 11.7%.
- At 34%, synthetic dressings represent the second largest market segment, but, growing at an AAGR of 7.1%, will drop to 30% in 2005.
- Biological and biosynthetic dressings will feature the fastest growth, rising at an AAGR of 14.2% during the period.